The 6th annual Orphan Drugs event returns to Berlin on the 15th -16th May 2017!
The global orphan drug market totalled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market. Germany is Europe’s largest pharma market but is recognised as having one of the toughest pricing policies in Europe.
SMi’s 6th annual Orphan Drugs will discuss the controversial German pricing mechanism as well as bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.
See the full program here